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Thus, even though the D16S3136 p values we obtained did not
reach statistical signi®cance, they are of interest because they
provide limited evidence for possible linkage disequilibrium at this
locus. In evaluating these data, it is important to consider that only
a limited subset of psoriatic patients may carry disease-predisposing
NOD2 variants (i.e., genetic heterogeneity) and that multiple allelic
variants of NOD2 might predispose to psoriasis (i.e., allelic
heterogeneity). Either of these situations would be expected to
weaken the statistical evidence for linkage disequilibrium.
Additional, con®rmatory studies will be required in order to
determine whether the clinical concomitance of psoriasis and CD is
due to the existence of one or more disease alleles at NOD2.
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XP43TO, Previously Classi®ed as Xeroderma Pigmentosum
Group E, Should be Reclassi®ed as Xeroderma Pigmentosum
Variant
To the Editor
Xeroderma pigmentosum (XP), a rare autosomal recessive disease
characterized by clinical and cellular hypersensitivity to ultraviolet
(UV) light (Cleaver and Kraemer, 1995), has been classi®ed into
eight genetic groups [A±G, and variant (V)]. XP-E (OMIM no.
278740) was reported to have biochemical heterogeneity regarding
a damage speci®c DNA binding (DDB) activity (Kataoka and
Fujiwara, 1991; Keeney et al, 1992): some strains lacked DDB
activity and were termed Ddb± XP-E, whereas others had activity
and were termed Ddb+ XP-E. After reinvestigating three Ddb+
XP-E cell strains, we recently reported that each had been
misclassi®ed, and based on their phenotypes after UV-irradiation
(unscheduled DNA synthesis, recovery of RNA synthesis, and
recovery of replicative DNA synthesis in the presence and absence
of caffeine) we tentatively reclassi®ed them as XP-F (OMIM no.
278760, XP89TO), XP-V (OMIM no. 278750, XP43TO), and
ultraviolet±sensitive syndrome (OMIM no. 600630, XP24KO)
strains (Itoh et al, 2000a). We therefore supported the tentative
proposal of Cleaver et al (1999) that mutations in the DDB2 gene
should be solely responsible for XP-E (Itoh et al, 2000a; Nichols
et al, 2000).
As the assignment of XP43TO as XP-V was based upon the
recovery of replicative DNA synthesis in the presence of caffeine,
we have analyzed the XP43TO for mutations in the XPV gene.
The XPV gene codes for DNA polymerase h (Johnson et al, 1999;
Masutani et al, 1999), an inducible, damage bypass DNA
polymerase (Yamada et al 2000). RT-PCR products from base
pairs 110±2410 of the XPV cDNA from XP43TO cells showed a
broad band compared with the products from normal Turu cells
(RT-PCR1, Fig 1a). This broadening was not seen, however, for
products from base pairs 898±2416 (RT-PCR2, Fig 1a). Thirty-
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one clones from the XP43TO RT-PCR1 band were sequenced
(Fig 1b). Twelve of these contained one of four types of exon
omission, whereas 19 contained one of three types of abnormal
splicing events around exon 4. Moreover, exon 4 contained a
G®T transversion at nucleotide 727 that would generate an
E164ter nonsense mutation (Fig 1b). By contrast, six independent
clones of this region from normal Turu cells had the sequence
reported by Masutani et al (1999) and Johnson et al (1999).
To verify that XP43TO cells carry this mutation in genomic
DNA, we performed PCR with genomic DNA and direct
sequencing of the region between exon 4 and intron 4 and
con®rmed the presence of the G®T transversion (Fig 2a).
Signi®cantly, nucleotide 727 is the highly conserved G(±1) at the
splice donor site of exon 4 (Fig 2b). These results con®rm that the
patient is either homozygous for the transversion or contained a
large deletion of the region in the other allele. In either case,
XP43TO should be classi®ed as XP-V.
Of the types of XP43TO cDNA found (Fig 1b), types 3, 4, and
5 resulted in frameshifts and type 7 had an in-frame stop codon in
the sequence inserted from intron 4. Types 1 and 2 would produce
a protein deleted for all of the seven DNA polymerase conserved
motifs as identi®ed by Yamada et al (2000) and Kannouche et al
(2001). Type 6 would give rise to a 30 amino-acid deletion
between the fourth and ®fth motif that could compromise the
function or stability of the protein. This large distribution of
mRNA types could be due to the transversion, or XP43TO could
harbor one or more mutations in the early introns, that could also
give rise to splice variants. Alternatively, some or all of the
alternative splicing events might occur at a low level in normal
cells, but the PCR might not be sensitive enough to detect them in
the Turu cells. That is, the distribution might include some minor
alternatively spliced forms present in normal cells.
We currently favor the hypothesis that all strains originally
reported as Ddb+ XP-E by cell fusion were originally misclassi®ed;
however, strict proof of this proposal is not possible because some
of these strains have been lost and others are available only as late
passage samples for which phenotypic analysis is not reliable.
Figure 1. Analysis of XPV cDNA from XP43TO. (A) RT-PCR
was performed on total RNA of XP43TO and normal Turu cells as
described (Itoh et al, 2000a, b) and PCR products were resolved on a
0.8% 1X Tris-acetate/EDTA (TAE) agarose gel and stained with
ethidium bromide. Primers were S1 [5¢-ACTGGACCTCCTAGAAAG
(bp 110±129)], S9 [5¢-GTCCTGGCAAAACTGGCCTG (bp 898±917)],
and AS24 [5¢-ATCCTACAGGCAAGCCTGAG (bp 2387±2416)]. RT-
PCR1 utilized primers S1 and AS24. RT-PCR2 utilized primers S9 and
AS24. M: 1 kb DNA ladder (Life Technologies). (B) The structures of
the abnormally spliced XPV cDNA from XP43TO cells deduced from
sequence analysis of 31 clones are shown in the context of the genomic
structure (Yuasa et al, 2000). Boxes show exons (E); lines show spliced
out introns. Arrows or arrowheads indicate a (putative) start codon (ATG)
or the G®T transversion at nucleotide 727, respectively. Parentheses
indicate wild-type exon nucleotides omitted. Also indicated are whether
the deletions cause frameshifts or produce an in-frame termination
codon (*).
Figure 2. Analysis of the XPV gene from XP43TO. (A) Sequence
of PCR products. PCR was performed using as template 200 ng
genomic DNA from XP43TO or normal Turu cells. Primers were S6
[5¢-GTCAGCCTATCTCGGCAGAC (bp 638±657)] and ASI1 [5¢-
GCAGTATGATGCTATGGAAGTAC] from intron 4 of the XPV
gene. PCR products were puri®ed on a 3% 1X TAE agarose gel and
sequenced. (B) Schematic representation of the mutation in exon 4.
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A Simple In Vivo System for Studying Epithelialization, Hair
Follicle Formation, and Invasion Using Primary Epidermal
Cells from Wild-Type and Transgenic Ornithine
Decarboxylase-Overexpressing Mouse Skin
To the Editor:
We report here a simple system for studying epithelialization, hair
follicle formation, and tumorigenesis by epidermal keratinocytes.
We have adapted a tracheal xenotransplantation assay originally
developed to evaluate invasiveness of human and mouse bronchial
epithelial cell lines (Terzaghi et al, 1978; Momiki et al, 1991). This
technique involves the seeding of epithelial cells into deepithelia-
lized rat tracheas that are then transplanted subcutaneously into
athymic nude mice. Both nontumorigenic and premalignant
epithelial cell lines reepithelialize these tracheas within a few
weeks by growing on the luminal surface of the tracheal grafts
(Smith et al, 1997). Stromal cells are contributed by the host mouse,
and result in the repopulation of cells and blood vessels in the
lamina propria of the tracheal grafts. Thus, tumor cell invasiveness
that is dependent on cell±matrix interactions can be fully evaluated
using this tracheal xenotransplant assay. Momiki and Klein-Szanto
have classi®ed the degree of invasion of the tracheal wall according
to the level of penetration of the cells being tested, with level 0
describing transplanted cells con®ned to the lining of the luminal
surface, level 2 involving in®ltration of the lamina propria, the pars
membranacea, and the trachealis muscle but not the adventitia, and
level 3 for when the malignant cells have reached the adventitia and
the whole tracheal wall is invaded (Momiki et al, 1991). This
method offers several advantages over in vitro assays in that it more
closely simulates the in vivo conditions in which epithelial tumor
cells invade neighboring tissue. Moreover, the cells under evalu-
ation are contained in a small, de®ned area of the tracheal graft that
also serves to separate the tested epithelial cells from endogenous
epithelial cells of the host athymic nude mouse. In®ltration of
grafted cultures of epithelial cells by host epithelial cells surrounding
the graft site can be a problem with some grafting procedures such
as skin reconstitution methods. In addition, far fewer cells are
needed to re-epithelialize the lumen of a tracheal graft than are
needed in other epithelial grafting procedures, thus offering the
potential to study stem cells derived from the cutaneous epithelium
where the number of inoculating cells is limiting. We have tested
the feasibility of growing primary cultures of murine keratinocytes
in tracheal xenotransplants in order to develop a simple, enclosed
system in which epidermal cells can be evaluated in vivo.
INVASION ASSAY
We used the tracheal xenotransplant procedure to evaluate invasive
properties of primary cultures of keratinocytes that express elevated
levels of ODC and/or v-Ha-ras. As a source of cells that express
high levels of ODC, we took advantage of the K6/ODC transgenic
mouse in which a keratin 6 promoter is used to target ODC
overexpression to outer root sheath cells of hair follicles (Megosh et
al, 1995). Primary keratinocytes were isolated from the skin of 2±3-
d-old K6/ODC transgenic mice and their normal littermates.
Whereas the keratin 6 promoter is not active in mice at age 2±3 d,
the keratin 6 promoter is turned on when the isolated keratinocytes
from the skin of these newborn animals are cultured, resulting in
high levels of ODC activity in the cultured keratinocytes. Half of
the cultured keratinocytes were infected with a replication-
defective v-Ha-ras retrovirus (Roop et al, 1986), and then
inoculated 2±3 d later in prepared deepithelialized rat tracheas
with a blunt-tipped needle at a concentration of 107 cells per ml
(0.050±0.125 ml per trachea depending on tracheal size). The
inoculated tracheas were sealed at the ends with hemoclips,
stretched onto thin Te¯on tubing, and implanted subcutaneously
into athymic mice for 5 wk to assay the degree of invasion of the
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